AGR2 and prostate carcinoma: Since further analyses could not be performed due to the insufficient number of existing studies, current data led us to a speculation that AGR2 might truly function as a tumour suppressor in some tumour types19, which however awaited future experimental verifications, especially in lung cancer, prostate cancer, ovarian cancer, gastric cancer, and colorectal cancer.